IOSP:NGS-Innospec Inc. (USD)

EQUITY | Specialty Chemicals | Nasdaq Global Select

Last Closing

USD 110.66

Change

-0.93 (-0.83)%

Market Cap

USD 1.60B

Volume

0.09M

Analyst Target

USD 90.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Innospec Inc develops, manufactures, blends, markets and supplies fuel additives, oilfield chemicals, personal care and other specialty chemicals. Its segments are Fuel Specialties; Performance Chemicals; and Octane Additives.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-27 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap
LIN Linde plc Ordinary Shares

N/A

USD 202.04B
BCPC Balchem Corporation

N/A

USD 5.79B
WDFC WD-40 Company

N/A

USD 3.71B
HWKN Hawkins Inc

N/A

USD 2.83B
GEVO Gevo Inc

N/A

USD 0.50B
LWLG Lightwave Logic Inc

N/A

USD 0.25B
HDSN Hudson Technologies Inc

N/A

USD 0.24B
NTIC Northern Technologies

N/A

USD 0.12B
ALTO Alto Ingredients Inc

N/A

USD 0.11B
LOOP Loop Industries Inc

N/A

USD 0.08B

ETFs Containing IOSP

PSCM Invesco S&P SmallCap Mate.. 4.63 % 0.29 %

N/A

USD 0.02B

Market Performance

  Market Performance vs. Industry/Classification (Specialty Chemicals) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -10.21% 68% D+ 39% F
Dividend Return 0.62% 20% F 10% F
Total Return -9.59% 68% D+ 38% F
Trailing 12 Months  
Capital Gain -10.21% 68% D+ 39% F
Dividend Return 0.62% 20% F 10% F
Total Return -9.59% 68% D+ 38% F
Trailing 5 Years  
Capital Gain 6.97% 45% F 56% F
Dividend Return 5.46% 33% F 16% F
Total Return 12.43% 45% F 53% F
Average Annual (5 Year Horizon)  
Capital Gain 10.07% 53% F 61% D-
Dividend Return 11.36% 58% F 61% D-
Total Return 1.28% 33% F 34% F
Risk Return Profile  
Volatility (Standard Deviation) 17.59% 84% B 80% B-
Risk Adjusted Return 64.57% 84% B 85% B
Market Capitalization 1.60B 83% B 83% B

Key Financial Ratios

  Ratio vs. Industry/Classification (Specialty Chemicals) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 17.70 46% 47%
Price/Book Ratio 2.32 47% 45%
Price / Cash Flow Ratio 14.06 28% 23%
Price/Free Cash Flow Ratio 11.64 47% 32%
Management Effectiveness  
Return on Equity 12.11% 76% 81%
Return on Invested Capital 11.55% 78% 80%
Return on Assets 7.24% 82% 91%
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector